1. Deng, Guo-Xiong, Yin, Rui-Xing, Guan, Yao-Zong, Wu, Jin-Zhen, Miao, Liu. 2020. Association of the NCAN-TM6SF2-CILP2-PBX4-SUGP1-MAU2 SNPs and gene-gene and gene-environment interactions with serum lipid levels. In Aging, 12, 11893-11913. doi:10.18632/aging.103361. https://pubmed.ncbi.nlm.nih.gov/32568739/
2. Wang, Xueli, Zhang, Yu, Song, Niping, Wang, Zhen, Zhang, Wei. 2023. CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer. In Heliyon, 9, e15535. doi:10.1016/j.heliyon.2023.e15535. https://pubmed.ncbi.nlm.nih.gov/37144183/
3. Li, Qinge, Pu, Danlan, Xia, Xuyun, Liu, Hua, Li, Ling. 2022. Serum Concentrations of Cartilage Intermediate Layer Protein 2 Were Higher in Overweight and Obese Subjects. In BioMed research international, 2022, 6290064. doi:10.1155/2022/6290064. https://pubmed.ncbi.nlm.nih.gov/35757483/
4. Salvador-Martín, Sara, Rubbini, Gianluca, Vellosillo, Perceval, Sanjurjo-Sáez, María, López-Fernández, Luis A. 2024. Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 173, 116299. doi:10.1016/j.biopha.2024.116299. https://pubmed.ncbi.nlm.nih.gov/38401525/
5. Huang, Feng, Peng, Yuanfei, Ye, Qing, Xu, Yangmei, Huang, Lijie. 2020. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study. In World journal of surgical oncology, 18, 274. doi:10.1186/s12957-020-02049-6. https://pubmed.ncbi.nlm.nih.gov/33099318/
6. Li, Junhang, Ma, Xiang, Yin, Cuihua. 2024. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases. In Scientific reports, 14, 11814. doi:10.1038/s41598-024-62742-4. https://pubmed.ncbi.nlm.nih.gov/38782984/